These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 3877719

  • 1. In-vitro activity of Ro-15-8074, a new oral cephalosporin.
    Peeters M, Piot P.
    J Antimicrob Chemother; 1985 Oct; 16(4):469-73. PubMed ID: 3877719
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin.
    Thomas MG, Lang SD.
    Antimicrob Agents Chemother; 1986 May; 29(5):945-7. PubMed ID: 3729354
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX, Neu HC.
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C.
    Infection; 1987 May; 15(2):122-4. PubMed ID: 3596808
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.
    Aldridge KE, Schiro DD, Sanders CV.
    Eur J Clin Microbiol; 1987 Oct; 6(5):564-9. PubMed ID: 3436316
    [Abstract] [Full Text] [Related]

  • 6. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A, Jungwirth R.
    Infection; 1991 Oct; 19(5):353-62. PubMed ID: 1800377
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of cefetamet (Ro 15-8074).
    Mittermayer H.
    Eur J Clin Microbiol; 1986 Oct; 5(5):530-4. PubMed ID: 3490975
    [No Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
    Sinai R, Hammerberg S, Marks MI, Pai CH.
    Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
    [Abstract] [Full Text] [Related]

  • 9. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT, Chao HP, Ho SW, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [Abstract] [Full Text] [Related]

  • 10. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Feb; 14(1):63-74. PubMed ID: 2013211
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Doern GV, Chapin KC.
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
    Fass RJ, Helsel VL.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):429-34. PubMed ID: 3777906
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.
    Jones RN, Fuchs PC, Barry AL, Ayers LW, Gerlach EH, Gavan TL.
    Antimicrob Agents Chemother; 1986 Dec; 30(6):961-3. PubMed ID: 3492961
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
    Mulligan ME.
    Infect Control; 1987 Jun; 8(6):241-4. PubMed ID: 3498702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
    Hohl P, Salfinger M, Kafader FM.
    Eur J Clin Microbiol; 1987 Aug; 6(4):487-8. PubMed ID: 3117539
    [No Abstract] [Full Text] [Related]

  • 20. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
    Matsuzaki K, Koyama H, Chiba A, Omika K, Harada S, Sato Y, Hasegawa M, Kobayashi I, Kaneko A, Sasaki J.
    Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.